Press Releases

Select Year  2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999

Date   September 02, 2010 K-V Pharmaceutical Company Receives Notification From New York Stock Exchange Of Compliance With Quantitative Continued Listing Standards August 09, 2010 K-V Pharmaceutical Company Announces the Election of New Independent Member to Board of Directors August 03, 2010 K-V Pharmaceutical Company Engages BDO USA, LLP as Independent Registered Accountants August 02, 2010 K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance with Continued Listing Standards July 15, 2010 K-V Pharmaceutical Names Thomas Mchugh Chief Financial Officer July 13, 2010 K-V Pharmaceutical Announces Resubmission to New Drug Application for Gestiva July 08, 2010 K-V Pharmaceutical Company Receives Letter From New York Stock Exchange Regarding Delayed Filing Of Its Annual Report On Form 10-K For Fiscal Year 2010 July 07, 2010 K-V Pharmaceutical Company Announces the Election of New Independent Member to Board of Director June 18, 2010 K-V Pharmaceutical Company Announces the Nomination and Appointment of New Independent Member to the Board of Directors June 11, 2010 K-V Pharmaceutical Company Announces New Board Members and Restructuring of Senior Executive Management 1 2